Trials / Conditions / Central Precocious Puberty

Central Precocious Puberty

17 registered clinical trials studyying Central Precocious Puberty — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Cent NCT06129539	Debiopharm International SA	Phase 3
Not Yet Recruiting	Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP NCT06487143	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 4
Completed	A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China NCT05341128	Takeda	—
Unknown	Evaluate the Efficacy and Safety of DWJ108J NCT06025409	Daewoong Pharmaceutical Co. LTD.	Phase 3
Completed	A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty NCT05341115	Takeda	Phase 4
Completed	A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants Wi NCT05029622	Ipsen	Phase 3
Completed	Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puber NCT04736602	Ipsen	Phase 3
Completed	A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among NCT02993926	Takeda	—
Completed	A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants NCT02427958	Takeda	Phase 4
Completed	Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty NCT03316482	Jin Soon Hwang	Phase 4
Terminated	Markers of Pubertal Suppression During Therapy for Precocious Puberty NCT02006680	University of Minnesota	—
Completed	Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty NCT02920515	Ruijin Hospital	Phase 4
Completed	Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precoc NCT01467882	Debiopharm International SA	Phase 3
Completed	The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) NCT01634321	Daewoong Pharmaceutical Co. LTD.	Phase 4
Completed	Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls NCT01278290	Hospital de Niños R. Gutierrez de Buenos Aires	Phase 3
Completed	Histrelin Subcutaneous Implant in Children With Central Precocious Puberty NCT00779103	Endo Pharmaceuticals	Phase 3
Unknown	Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children NCT00438217	University of Pisa	Phase 4